Erythromycin enhances gastric motility by acting as a motilin receptor agonist. Motilin is a gastrointestinal hormone that stimulates the migrating motor complex (MMC), a cyclical pattern of muscle contractions that clears the stomach of undigested food.
- Erythromycin binds to these motilin receptors, mimicking the effects of motilin itself. This binding triggers increased muscle contractions in the stomach and small intestine. Consequently, gastric emptying is accelerated, relieving symptoms of gastroparesis.
The mechanism is relatively straightforward: increased motilin receptor activation leads to stronger, more frequent contractions, moving food through the digestive system more efficiently.
Clinical studies have demonstrated this effect. For example, studies show a significant increase in gastric emptying rate after erythromycin administration in patients with delayed gastric emptying.
Dosage and timing of erythromycin administration are crucial for optimal results. Consult your physician for personalized recommendations. Individual responses to erythromycin vary. What works well for one patient might not be as effective for another. While erythromycin offers benefits, it’s not a cure-all. It’s often used alongside other therapies for comprehensive gastroparesis management.
Remember to discuss any potential side effects with your doctor. While generally well-tolerated, erythromycin can cause nausea, diarrhea, or abdominal cramping in some individuals.
